IRIDEX Q1 2026 Earnings Narrowed Loss Surpasses Estimates Amid Operational Focus ADAML Q1 2026 Earnings Significant EPS Beat as Preferred Stock Delivers Strong Performance Rigel Pharmaceuticals Q1 2026 Earnings EPS Falls Short of Expectations ATNI Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter Nuvalent Inc NUVL Q1 2026 Earnings Slightly Wider Loss No Revenue Yet as PreClinical Pipeline Progresses IVF Q3 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises 375